Screener
Arcus Biosciences RCUS Shares (Diluted)
Shares (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Arcus Biosciences in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.
The source filing: Arcus Biosciences’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:11 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001724521-26-000044
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Income tax expense | — | — | — | — |
| Net income (loss) | $(91) | — | $(219) | $(112) |
| Net income (loss) per share: | ||||
| Basic | $(0.72) | — | $(1.74) | $(1.09) |
| Diluted | $(0.72) | — | $(1.74) | $(1.09) |
| Shares used to compute net income (loss) per share: | ||||
| Basic | 126.1 | 106.1 | 125.7 | 102.3 |
| Diluted | 126.1 | 106.5 | 125.7 | 102.3 |
Item 1. Financial Statements
FAQ
- What is Arcus Biosciences's shares (diluted)?
- Arcus Biosciences (RCUS) reported shares (diluted) of 126.1M in Q2 2026.
- How has Arcus Biosciences's shares (diluted) changed year-over-year?
- Arcus Biosciences's shares (diluted) increased by 18.4% year-over-year, from 106.5M to 126.1M.
- What is the long-term trend for Arcus Biosciences's shares (diluted)?
- Over 4 years (2021 to 2025), Arcus Biosciences's shares (diluted) has grown at a 10.5% compound annual growth rate (CAGR), from 280.9M to 418.8M.
- What does shares (diluted) mean?
- The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.
Ask your AI about Arcus Biosciences's shares (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude